About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalJan 15, 2025 · 7:57pm ET

PALIPALISADE BIO, INC.

Palisade Bio Completes SAD Cohorts and Starts MAD Cohorts in PALI-2108 Trial

The trial targets ulcerative colitis treatment.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+61.1%

RVOL

13.3x

Max high

$2.90

Fuel

8m

Regulatory and ClinicalJan 15, 2025 · 7:57pm ET

PALIPALISADE BIO, INC.+61.1%

Palisade Bio Completes SAD Cohorts and Starts MAD Cohorts in PALI-2108 Trial

RVOL

13.3x

Max high

$2.90

Fuel

8m

Regulatory and ClinicalJan 15, 2025 · 7:46pm ET

BMRABIOMERICA INC

Biomerica, Inc. Granted Approval for Fortel® PSA Screening Test by UAE Ministry of Health and Prevention

The approval was announced on January 16, 2025.

Regulatory and ClinicalJan 15, 2025 · 7:46pm ET

BMRABIOMERICA INC+257.6%

Biomerica, Inc. Granted Approval for Fortel® PSA Screening Test by UAE Ministry of Health and Prevention

Regulatory and ClinicalJan 14, 2025 · 7:59pm ET

ONCYOncolytics Biotech, Inc. Common Shares

Oncolytics Biotech Receives PEI Approval to Continue GOBLET Study Enrollment

The Paul-Ehrlich-Institute granted approval for Cohort 5.

Regulatory and ClinicalJan 14, 2025 · 7:59pm ET

ONCYOncolytics Biotech, Inc. Common Shares+53.1%

Oncolytics Biotech Receives PEI Approval to Continue GOBLET Study Enrollment

Regulatory and ClinicalJan 14, 2025 · 7:48pm ET

OSTXOS Therapies Incorporated

OS Therapies' Phase 2b Trial Achieves Primary Endpoint for Lung Metastatic Osteosarcoma

Company announces successful clinical trial results for OST-HER2.

Regulatory and ClinicalJan 14, 2025 · 7:48pm ET

OSTXOS Therapies Incorporated+103.6%

OS Therapies' Phase 2b Trial Achieves Primary Endpoint for Lung Metastatic Osteosarcoma

Regulatory and ClinicalJan 13, 2025 · 7:57pm ET

AIFFFIREFLY NEUROSCIENCE, INC.

Firefly Neuroscience Advances Research on Brain Age Assessment Using BNA™ Technology

Company leverages FDA-cleared platform for new study.

Regulatory and ClinicalJan 13, 2025 · 7:57pm ET

AIFFFIREFLY NEUROSCIENCE, INC.+206.8%

Firefly Neuroscience Advances Research on Brain Age Assessment Using BNA™ Technology

Regulatory and ClinicalJan 13, 2025 · 3:52pm ET

SNGXSOLIGENIX, INC.

Soligenix Reports Positive Patient Responses to HyBryte Therapy

Over 70% of patients achieved 'Treatment Success' in a study.

Regulatory and ClinicalJan 13, 2025 · 3:52pm ET

SNGXSOLIGENIX, INC.+55.8%

Soligenix Reports Positive Patient Responses to HyBryte Therapy

Regulatory and ClinicalJan 13, 2025 · 7:46am ET

PHIOPhio Pharmaceuticals Corp.

Phio Pharmaceuticals Reports 100% Tumor Clearance in Two Patients Using PH-762

Results from Phase 1b cancer study.

Regulatory and ClinicalJan 13, 2025 · 7:46am ET

PHIOPhio Pharmaceuticals Corp.+519.6%

Phio Pharmaceuticals Reports 100% Tumor Clearance in Two Patients Using PH-762

1
…
22
23
24

RVOL

9.3x

Max high

$10.16

Fuel

1h 21m

RVOL

9.6x

Max high

$1.24

Fuel

6m

RVOL

14.1x

Max high

$8.45

Fuel

9m

RVOL

9.2x

Max high

$5.80

Fuel

2h 2m

RVOL

11.6x

Max high

$5.00

Fuel

12m

RVOL

11.6x

Max high

$9.79

Fuel

3h 13m